Revolutionary Decision-making Genomic Tests to Target Mutations in Cancer-related Genes

Wednesday, September 27, 2017 7 PM
CLU Gilbert Sports and Fitness Center, 130 Overton Court, rooms 253/254 (second floor)

Andre de Fusco

André de Fusco is a 20-year technology entrepreneur with hands-on experience leading early-stage through IPO companies in various high technology application segments. In addition to his current interest in developing technology for personalized medicine and molecular diagnostics as chief executive officer of Cynvenio, he was previously president and chief executive officer of Sabeus, Inc., a provider of fiberoptic systems to the energy industry; director and president of Neven Vision, Inc., a novel facial biometrics company (later acquired by Google); and president and chief executive officer of VOIP transmission equipment manufacturer ACT Networks, Inc., (NASDAQ: ANET), which he joined from Nortel Europe.

From 2002 to 2007, Mr. de Fusco chaired the technology committee of the American Electronics Association (now TechAmerica) and served as an AEA’s industry delegate to China. He currently serves on the advisory board of directors of the Center for Law, Brain and Behavior at Massachusetts General Hospital.

Mr. de Fusco holds a B.A. in political science from the University of California, Los Angeles and a certificate in general management from Anderson’s School of Business.